Research output per year
Research output per year
- 18 results
Search results
-
2025
The association between ethnicity, socioeconomic position and outcomes following initiation of methotrexate in Juvenile Idiopathic Arthritis
The UK JIA Biologics Register, Beesley, R., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Southwood, T. R., Hyrich, K. & Humphreys, J. H., 3 Oct 2025, (Accepted/In press) In: EULAR Rheumatology Open.Research output: Contribution to journal › Article › peer-review
-
2024
Comparative effectiveness of a second TNF inhibitor versus a non-TNF biologic in the treatment of polyarticular course juvenile idiopathic arthritis
Mannion, M. L., Amin, S., Balevic, S., Chang, M.-L., Correll, C. K., Kearsley-Fleet, L., Hyrich, K. & Beukelman, T., 22 Mar 2024, (Accepted/In press) In: Arthritis Care & Research.Research output: Contribution to journal › Article › peer-review
Open AccessFile13 Downloads (Pure) -
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis
CLUSTER Consortium, 19 Jul 2024, In: Arthritis and Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes following anti-TNF originator to biosimilar switching in children and young people with Juvenile Idiopathic Arthritis (JIA)
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R. & Hyrich, K., 3 Jun 2024, In: The Lancet Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Towards Stratified Treatment of JIA: Machine Learning Identifies Subtypes in Response to Methotrexate from Four UK Cohorts
CLUSTER Consortium, Shoop-Worrall, S. J. W., Lawson-Tovey, S., Wedderburn, L. R., Hyrich, K. L. & Geifman, N., 1 Feb 2024, In: EBioMedicine. 100, 104946.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
UK JIA Biologic Registers, Kearsley-Fleet, L. & Hyrich, K. L., 1 May 2023, In: Rheumatology. 62, 5, p. 1926-1935 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
CLUSTER Consortium, 13 Jul 2023, In: Pediatric Rheumatology. 21, 70.Research output: Contribution to journal › Article › peer-review
Open Access3 Downloads (Pure) -
2021
Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries
Kearsley-Fleet, L., Klotsche, J., van Straalen, J. W., Costello, W., D’Angelo, G., Giancane, G., Horneff, G., Klein, A., Láday, M., Lunt, M., de Roock, S., Ruperto, N., Schoemaker, C., Vijatov-Djuric, G., Vojinovic, J., Vougiouka, O., Wulffraat, N. M., Hyrich, K., Minden, K. & Swart, J. F., 6 Oct 2021, In: Rheumatology (Print). keab641.Research output: Contribution to journal › Article › peer-review
Open Access -
2020
Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
Kearsley-Fleet, L., Heaf, E., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T., Thomson, W., Hyrich, K., Biologics for Children with Rheumatic Diseases Study (BCRD) & British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN), 1 Apr 2020, In: The Lancet Rheumatology. 2, 4, p. E217-E226Research output: Contribution to journal › Article › peer-review
Open Access -
2019
Methotrexate Persistence and Adverse Drug Reactions in Patients with Juvenile Idiopathic Arthritis.
Kearsley-Fleet, L., Vicente González, L., Steinke, D., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R. & Hyrich, K., 2019, In: Rheumatology (Oxford).Research output: Contribution to journal › Article › peer-review
Open Access -
Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra
Kearsley-Fleet, L., Beresford, M. W., Davies, R., De Cock, D., Baildam, E., Foster, H. E., Southwood, T. R., Thomson, W., Hyrich, K. L. & Biologics for Children with Rheumatic Diseases Study (BCRD), 1 Jan 2019, In: Rheumatology (Oxford). 58, 1, p. 94-102 8 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Downloads (Pure) -
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
Davies, R., Decock, D., Kearsley-Fleet, L., Southwood, T., Baildman, E., Beresford, M. W., Foster, H. E., Thomson, W., Ramanan, A. & Hyrich, K., 12 Oct 2019, (E-pub ahead of print) In: Rheumatology (Oxford).Research output: Contribution to journal › Article › peer-review
Open Access -
Use and Effectiveness of Rituximab in Children and Young People with Juvenile Idiopathic Arthritis in a Cohort Study in the United Kingdom
Kearsley-Fleet, L., Sampath, S., McCann, L. J., Baildam, E., Beresford, M. W., Davies, R., De Cock, D., Foster, H. E., Southwood, T. R., Thomson, W., Hyrich, K. L. & Biologics for Children with Rheumatic Diseases Study (BCRD), 1 Feb 2019, In: Rheumatology (Oxford). 58, 2, p. 331-335 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2016
Factors associated with choice of biologic among children with juvenile idiopathic arthritis: Results from two UK paediatric biologic registers
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M., Foster, H., Southwood, T., Thomson, W. & Hyrich, K., 2016, In: Rheumatology (Print). 55, 9, p. 1556-1565Research output: Contribution to journal › Article › peer-review
Open Access -
Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
Kearsley-Fleet, L., Davies, R., Lunt, M., Southwood, T. & Hyrich, K., 2016, In: Rheumatology. 55, 5, p. 840-847Research output: Contribution to journal › Article › peer-review
Open Access -
2015
Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Kearsley-Fleet, L., Hyrich, K. L., Davies, R., Lunt, M. & Southwood, T. R., 30 Jan 2015, In: Rheumatology (Oxford, England). 54, 7, p. 1279-1285Research output: Contribution to journal › Article › peer-review
-
Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept. Results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Davies, R., Southwood, T. R., Kearsley-Fleet, L., Lunt, M., Hyrich, K. L. & British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN), 2015, In: Arthritis & rheumatology (Hoboken, N.J.). 67, 9, p. 2487-2494 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2011
Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
Southwood, T. R., Foster, H. E., Davidson, J. E., Hyrich, K. L., Cotter, C. B., Wedderburn, L. R., Hull, R. G., Venning, H. E., Rahman, J. K. & Cummins, C. L., Jan 2011, In: Rheumatology. 50, 1, p. 189-195 6 p.Research output: Contribution to journal › Article › peer-review